These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30187002)

  • 1. Systematic review of clobazam use in patients with status epilepticus.
    Mahmoud SH; Rans C
    Epilepsia Open; 2018 Sep; 3(3):323-330. PubMed ID: 30187002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clobazam for treatment of refractory status epilepticus.
    Madžar D; Geyer A; Knappe RU; Gollwitzer S; Kuramatsu JB; Gerner ST; Hamer HM; Huttner HB
    BMC Neurol; 2016 Oct; 16(1):202. PubMed ID: 27769254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
    Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of clobazam in certain forms of status epilepticus and in startle-induced epileptic seizures.
    Tinuper P; Aguglia U; Gastaut H
    Epilepsia; 1986; 27 Suppl 1():S18-26. PubMed ID: 3743522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobazam: An effective add-on therapy in refractory status epilepticus.
    Sivakumar S; Ibrahim M; Parker D; Norris G; Shah A; Mohamed W
    Epilepsia; 2015 Jun; 56(6):e83-9. PubMed ID: 25963810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center.
    Montenegro MA; Arif H; Nahm EA; Resor SR; Hirsch LJ
    Clin Neuropharmacol; 2008; 31(6):333-8. PubMed ID: 19050410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy.
    Montenegro MA; Cendes F; Noronha AL; Mory SB; Carvalho MI; Marques LH; Guerreiro CA
    Epilepsia; 2001 Apr; 42(4):539-42. PubMed ID: 11440350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M; Riva R; Albani F; Baruzzi AA
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobazam in the treatment of epilepsy: a review of the literature.
    Remy C
    Epilepsia; 1994; 35 Suppl 5():S88-91. PubMed ID: 8039479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clobazam as a new antiepileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in Japan.
    Sugai K
    Epilepsia; 2004; 45 Suppl 8():20-5. PubMed ID: 15610190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.
    Farrokh S; Bon J; Erdman M; Tesoro E
    Pharmacotherapy; 2019 Mar; 39(3):297-316. PubMed ID: 30723940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of ketogenic diet use in adult patients with status epilepticus.
    Mahmoud SH; Ho-Huang E; Buhler J
    Epilepsia Open; 2020 Mar; 5(1):10-21. PubMed ID: 32140640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
    Lee EH; Yum MS; Choi HW; Ko TS
    Clin Neuropharmacol; 2013; 36(1):4-7. PubMed ID: 23334068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A pharmacological profile of clobazam (Mystan), a new antiepileptic drug].
    Nakajima H
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):117-22. PubMed ID: 11530681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of certain forms of status epilepticus by means of a single oral dose of clobazam].
    Gastaut H; Tinuper P; Aguglia U; Lugaresi E
    Rev Electroencephalogr Neurophysiol Clin; 1984 Dec; 14(3):203-6. PubMed ID: 6528075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobazam in long-term epilepsy treatment: sustained responders versus those developing tolerance.
    Singh A; Guberman AH; Boisvert D
    Epilepsia; 1995 Aug; 36(8):798-803. PubMed ID: 7635098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy.
    Sennoune S; Mesdjian E; Bonneton J; Genton P; Dravet C; Roger J
    Ther Drug Monit; 1992 Aug; 14(4):269-74. PubMed ID: 1519299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1 year.
    Mills JK; Lewis TG; Mughal K; Ali I; Ugur A; Whitehouse WP
    Seizure; 2011 Jun; 20(5):402-5. PubMed ID: 21414810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB.
    Kinoshita M; Ikeda A; Begum T; Terada K; Shibasaki H
    J Neurol Sci; 2007 Dec; 263(1-2):44-8. PubMed ID: 17588610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.